SC 13G

Company

Quince Therapeutics, Inc.

Filed

February 12, 2024

Accession Number

0001104659-24-013830

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →